NovaBay Pharmaceuticals Launches First of Several New Products to Expand Avenova LineBusiness Wire • 05/17/21
NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/09/21
NovaBay Pharmaceuticals' (NBY) CEO Justin Hall on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/26/21
NovaBay Pharmaceuticals Reports 2020 Fourth Quarter and Full Year Financial ResultsBusiness Wire • 03/25/21
NovaBay Pharmaceuticals to Hold 2020 Fourth Quarter and Full Year Conference Call on March 25Business Wire • 03/18/21
NovaBay Pharmaceuticals to Participate in Virtual 33rd Annual Roth ConferenceBusiness Wire • 03/08/21
NovaBay Pharmaceuticals Now Included in EPA N Listing of Products That Kill SARS-CoV-2Business Wire • 12/14/20
NovaBay Pharmaceuticals Expands Avenova's Geographic Reach to Australia with New Exclusive Distribution AgreementBusiness Wire • 11/23/20
NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/13/20
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November 12Business Wire • 10/30/20
NovaBay Pharmaceuticals Regains Compliance with NYSE American Listing StandardsBusiness Wire • 10/12/20
NovaBay Pharmaceuticals Expands Avenova® Consumer Marketing through Affiliate Programs and Enhanced Lifestyle Public RelationsBusiness Wire • 09/24/20